$SPY

$SPY. The ticker your group chat won't shut up about. Here's the autopsy. SPY is not a company. It is a parasite that charges you 0.03% annually to do nothing but hold the same stocks everyone else does. You are not investing, you are not diversifying, you are paying Vanguard a tax to participate in the mass delusion that owning fractional shares of the Magnificent Seven is called portfolio management. The current price is $742.09, sitting just 2.1% from the 52-week high of $757.64, which means you are buying at peak confidence after a 20.7% tear from the lows. The RSI is neutered at 47.9 — not oversold, not overbought, just aggressively cooked. More brutal: puts are dominating the tape at $123.8M versus calls at $53.9M over the last week, and the flow is screaming bearish while retail keeps clicking buy on their brokerage app because Cathie Wood told them to own the future. SPY floats on concentration risk so acute that funds are literally hitting regulatory limits on how much of this basket they can hold without breaking the law, yet you think you are making a sophisticated choice by parking your 401K contribution here. You are not diversified, you are not ahead, you are not thinking — you are a collection account for the asset management oligopoly. Here is your screenshot line: SPY is the investment equivalent of ordering a salad at Chick-fil-A and calling yourself a vegetarian.